<DOC>
	<DOCNO>NCT01542463</DOCNO>
	<brief_summary>This study conduct Europe . The aim study evaluate use insulin detemir ( Levemir® ) insufficiently control patient type 1 type 2 diabetes .</brief_summary>
	<brief_title>Evaluation Use Levemir® Insufficiently Controlled Patients With Type 1 Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Detemir</mesh_term>
	<criteria>Patients insufficiently control type 1 type 2 diabetes mellitus previous therapy</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>